Shareholders of Nitta Gelatin India Limited have approved the appointment of Mr. Arun K Vijayan IAS as a Nominee Director on the company’s Board. The resolution was passed through a postal ballot process concluded on September 8, 2026, with results declared on September 9, 2026.

The appointment follows a nomination by Kerala State Industrial Development Corporation Limited (KSIDC), a joint venture partner alongside Nitta Gelatin Inc. Mr. Vijayan’s term is subject to retirement by rotation as per the Companies Act, 2013.

Voting Breakdown

The ordinary resolution required simple majority approval. Of the 9,079,160 total shares eligible to vote, 6,835,310 votes were polled, representing a participation rate of 75.29%.

Promoter shareholders cast unanimous support, voting all held shares in favour. Among public shareholders, institutional investors showed slightly lower support at 93.87% compared to non-institutional investors at 96.28%. However, dissent remained minimal overall, with only 0.05% of total polled votes cast against the resolution.

What the Numbers Show

The voting pattern highlights a distinct divergence between promoter and public shareholder engagement. While promoters participated at 100% capacity, public shareholder participation was significantly lower, with institutions polling only 19.59% of their holdings and non-institutions just 2.44%. Despite this lower turnout among retail and institutional public shareholders, the high margin of approval (99.95%) indicates broad consensus on the board composition change driven by the state-owned partner KSIDC.

MarketsandMarkets projects the global gelatin market will grow from USD 4.59 billion in 2026 to USD 6.43 billion by 2031, registering a compound annual growth rate (CAGR) of 7.0%. The expansion is driven by increasing demand for natural, protein-based ingredients and clean-label formulations across food, pharmaceuticals, and personal care sectors.

Market Dynamics

The report highlights that rising consumer interest in health and wellness products is a primary catalyst for this growth. Manufacturers are responding to demand for multifunctional ingredients that offer both nutritional and functional benefits, such as gelling, stabilizing, and film-forming properties. This shift is evident in the expanding use of gelatin in confectionery, functional foods, dietary supplements, and pharmaceutical formulations.

Segment Analysis

Marine gelatin is projected to be the fastest-growing source segment during the forecast period. Derived from fish skin, scales, and bones, it serves as a viable alternative to bovine and porcine sources, aligning with Halal and Kosher requirements. This segment benefits from growing demand in nutraceuticals, cosmetics, and functional foods, alongside efforts to utilize fish processing by-products sustainably.

In terms of application, the health and nutrition segment is expected to register the fastest growth. Increasing awareness of preventive healthcare, physical fitness, and healthy aging is driving demand for gelatin in nutraceutical formulations, protein-enriched products, and collagen-based wellness solutions. Key applications include gummy supplements, sports nutrition, and products targeting joint, bone, and skin health.

Regional Outlook

Asia Pacific is identified as the fastest-growing region in the gelatin industry. Growth in this region is supported by expanding food, beverage, pharmaceutical, and nutraceutical industries in countries such as China, India, and Japan. Rising consumer health consciousness, increased consumption of dietary supplements, and growing pharmaceutical production capacity are strengthening regional demand.

Competitive Landscape

The global gelatin market features several key players, including Darling Ingredients (US), Tessenderlo Group (Belgium), GELITA (Germany), Nitta Gelatin (Japan), Lapi Gelatine s.p.a (Italy), India Gelatine & Chemicals Ltd. (India), Narmada Gelatines Ltd (India), Nippi, Inc. (Japan), Weishardt (France), Trobas B.V. (Netherlands), and various Chinese manufacturers such as Shandong Hengxin Biotech Co., Ltd. and Baotou Dongbao Bio-Tech Co., Ltd.

What the Numbers Show

The projected growth from USD 4.59 billion to USD 6.43 billion over five years indicates a robust expansion trajectory, with the market adding approximately USD 1.84 billion in value. The emphasis on marine gelatin and health applications suggests a structural shift in demand drivers, moving beyond traditional food uses toward specialized, health-conscious formulations. This diversification likely reduces dependency on single-source animal by-products while tapping into higher-margin nutraceutical segments.